Alpha 2.0
Login Register
» Articles » PMID: 26248830

N-of-1 Trials in Oncology

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2015 Aug 8
PMID 26248830
Citations 9
Authors
Laurence Collette
Bertrand Tombal
Affiliations
Soon will be listed here.
Citing Articles

Individualized therapy trials: navigating patient care, research goals and ethics.

Bodilly Kane P, Bittlinger M, Kimmelman J Nat Med. 2021; 27(10):1679-1686.

PMID: 34642487 DOI: 10.1038/s41591-021-01519-y.

Matching methods in precision oncology: An introduction and illustrative example.

Weymann D, Laskin J, Jones S, Lim H, Renouf D, Roscoe R Mol Genet Genomic Med. 2020; 9(1):e1554.

PMID: 33237632 PMC: 7963415. DOI: 10.1002/mgg3.1554.

Precision Medicine: From "Omics" to Economics towards Data-Driven Healthcare - Time for European Transformation.

Lacombe D, Liu L, Meunier F, Golfinopoulos V Biomed Hub. 2020; 2(Suppl 1):212-221.

PMID: 31988951 PMC: 6945945. DOI: 10.1159/000480117.

Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?.

Rossi E, Zamarchi R Front Genet. 2019; 10:958.

PMID: 31681412 PMC: 6811661. DOI: 10.3389/fgene.2019.00958.

Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases.

Sampayo-Cordero M, Miguel-Huguet B, Pardo-Mateos A, Malfettone A, Perez-Garcia J, Llombart-Cussac A Orphanet J Rare Dis. 2019; 14(1):230.

PMID: 31639024 PMC: 6805333. DOI: 10.1186/s13023-019-1202-6.